Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Turubanova

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|June 12, 2025
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effectsTikhon Redkin, Victoria Turubanova
Pharmaceutics|May 27, 2026
Photo- and Immunotherapy Interface: Can Dendritic Cell Vaccines Overcome the Limitations of PDT?Natalia Shilyagina, Yevgeniya Sannova, Victoria Turubanova, et al.
Cancers|December 9, 2023
Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for ResearchMariia Saviuk, Ekaterina Sleptsova, Tikhon Redkin, et al.
International Journal of Molecular Sciences|January 28, 2026
From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy SelectionEkaterina Sleptsova, Olga Vershinina, Mikhail Ivanchenko, et al.
Cancers|August 28, 2025
Explainable Machine Learning Models for Glioma Subtype Classification and Survival PredictionOlga Vershinina, Victoria Turubanova, Mikhail Krivonosov, et al.
Pharmaceutics|June 26, 2026
Ferroptosis with Contributions from Apoptosis and Necroptosis in Porphyrazine III-Based Photodynamic Therapy of Primary Human GliomasEkaterina Sleptsova, Alina Khuzina, Daria Sachkova, et al.
Cell Death & Disease|December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosisMaria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|June 12, 2025
Dendritic cell-derived exosomes as anti-cancer cell-free agents: new insights into enhancing immunogenic effectsTikhon Redkin, Victoria Turubanova
Pharmaceutics|May 27, 2026
Photo- and Immunotherapy Interface: Can Dendritic Cell Vaccines Overcome the Limitations of PDT?Natalia Shilyagina, Yevgeniya Sannova, Victoria Turubanova, et al.
Cancers|December 9, 2023
Unexplained Causes of Glioma-Associated Epilepsies: A Review of Theories and an Area for ResearchMariia Saviuk, Ekaterina Sleptsova, Tikhon Redkin, et al.
International Journal of Molecular Sciences|January 28, 2026
From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy SelectionEkaterina Sleptsova, Olga Vershinina, Mikhail Ivanchenko, et al.
Cancers|August 28, 2025
Explainable Machine Learning Models for Glioma Subtype Classification and Survival PredictionOlga Vershinina, Victoria Turubanova, Mikhail Krivonosov, et al.
Pharmaceutics|June 26, 2026
Ferroptosis with Contributions from Apoptosis and Necroptosis in Porphyrazine III-Based Photodynamic Therapy of Primary Human GliomasEkaterina Sleptsova, Alina Khuzina, Daria Sachkova, et al.
Cell Death & Disease|December 20, 2022
DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosisMaria Vedunova, Victoria Turubanova, Olga Vershinina, et al.
Pageof 1